Arcus Biosciences, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Arcus Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $270.00K, a 26900.00% increase year-over-year.
- Arcus Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $1.75M, a 1668.69% increase year-over-year.
- Arcus Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $643.00K.
- Arcus Biosciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $1.00K.
- Arcus Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $188.00K, a 97.89% increase from fiscal 2018.
- Arcus Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $95.00K, a 179.41% increase from fiscal 2017.
- Arcus Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $34.00K, a 70.00% increase from fiscal 2016.
- Arcus Biosciences, Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $20.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-09-30 | $270.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $1.75M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $643.00K 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $188.00K 10-K · filed 2022-02-23 | |
| 2019-09-30 | $1.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $99.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $95.00K 10-K · filed 2021-02-25 | |
| 2018-03-31 | $80.00K 10-Q · filed 2019-11-05 | |
| 2017-12-31 | $34.00K 10-K · filed 2019-03-05 | |
| 2016-12-31 | $20.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |